Plant ID: NPO21410
Plant Latin Name: Populus balsamifera
Taxonomy Genus: Populus
Taxonomy Family: Salicaceae
NCBI TaxonomyDB:
73824
Plant-of-the-World-Online:
776600-1
Anodyne; Antiinflammatory; Antiscorbutic; Antiseptic; Cathartic; Diuretic; Expectorant; Febrifuge; Stimulant; Tonic
Belgium; Canada; United States; China; France
Cytochrome P450 Enzymes: | CYP1A2; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0071276; cellular response to cadmium ion | 1.493E-05 | 1.280E-01 | CYP1A2, MAPK1 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 7.080E-05 | 2.569E-01 | MAPK1, MAPT |
BP | GO:0007610; behavior | GO:0007610; behavior | 8.511E-05 | 2.615E-01 | MAPK1, MAPT, NPC1 |
BP | GO:0009987; cellular process | GO:1900034; regulation of cellular response to heat | 9.608E-05 | 2.615E-01 | MAPK1, MAPT |
BP | GO:0050896; response to stimulus | GO:0014070; response to organic cyclic compound | 2.064E-04 | 3.469E-01 | CYP1A2, MAPK1, NPC1 |
MF | GO:0005488; binding | GO:0019902; phosphatase binding | 4.251E-04 | 5.143E-01 | MAPK1, MAPT |
CC | GO:0044464; cell part | GO:0030424; axon | 1.040E-03 | 5.659E-01 | MAPK1, MAPT |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 8.281E-04 | 5.659E-01 | CYP1A2 |
CC | GO:0016020; membrane | GO:0045121; membrane raft | 1.348E-03 | 6.053E-01 | MAPK1, NPC1 |
MF | GO:0005488; binding | GO:0034452; dynactin binding | 2.276E-03 | 6.884E-01 | MAPT |
MF | Unclassified; | GO:0004707; MAP kinase activity | 2.896E-03 | 7.303E-01 | MAPK1 |
MF | Unclassified; | GO:0004708; MAP kinase kinase activity | 3.103E-03 | 7.303E-01 | MAPK1 |
MF | GO:0003824; catalytic activity | GO:0008353; RNA polymerase II carboxy-terminal domain kinase activity | 3.309E-03 | 7.303E-01 | MAPK1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 4.162E-04 | 3.199E-02 | MAPK1, MAPT |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04010 | MAPK signaling pathway | 9.553E-04 | 3.199E-02 | MAPK1, MAPT |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 9.997E-04 | 3.199E-02 | CYP1A2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.432E-02 | 3.441E-02 | MAPK1 |
09150 Organismal Systems | 09151 Immune system | hsa04662 | B cell receptor signaling pathway | 1.452E-02 | 3.441E-02 | MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.452E-02 | 3.441E-02 | MAPK1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.373E-02 | 3.441E-02 | CYP1A2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04350 | TGF-beta signaling pathway | 1.670E-02 | 3.441E-02 | MAPK1 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 1.472E-02 | 3.441E-02 | MAPK1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.452E-02 | 3.441E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |